Trials / Completed
CompletedNCT05373459
Effect of a Third COVID-19 Booster Among Health Care Workers
Effect of a Third COVID-19 Booster on COVID-19 Infection Rate and Return to Works During Fifth Wave COVID-19 Among Health Care Workers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,167 (actual)
- Sponsor
- Hong Kong Sanatorium & Hospital · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A new wave of COVID-19 infections, mainly caused by the Omicron/ Delta variant, has been sweeping the globe since the start of 2022. In response, the administration of a third dose of COVID-19 vaccine was considered to address potential waning immunity over time and reduced effectiveness against the Omicron/ Delta variant. The pandemic also resulted in many infections among health care workers (HCWs) and their households. In this study, a retrospective analysis would perform on risk of COVID-19 infection and their outcome in relation to their COVID-19 vaccination history by using the data repository from one of the Hong Kong private hospitals. HCWs were required to submit a standardized online self-declaration form for report of 1) demographic of the HCWs, 2) symptoms related history and 3) COVID-19 exposure history once they were COVID-19 confirmed by rapid antigen test against COVID-19 and/or polymerase chain reaction (PCR) test for COVID-19. Subsequent follow up such as contact tracing, COVID-19 PCR testing results of these HCWs and status of return to work were captured by the infection control team in a systematic manner.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Third COVID-19 booster | Third COVID-19 booster |
Timeline
- Start date
- 2022-05-16
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2022-05-13
- Last updated
- 2024-02-28
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT05373459. Inclusion in this directory is not an endorsement.